High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer

I. Braunschweig, N. Q. Mirza, G. Rondon, J. Lauppe, R. Mehra, J. Gajewski, M. Körbling, Y. O. Huh, D. Geisler, A. P. Gee, R. Champlin, D. Przepiorka

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences